Webinars

Tutors

• Dr Fran Lloyd
  

Aim

To provide additional information to HCP who are interested in being a DPP for a community pharmacist.

Learning outcomes

null

Tutors

• Dr Dan Corbett
  Senior Lecturer (Digital Education), School of Pharmacy QUB

Aim

To provide pharmacists with an understanding of the emerging role of digital diagnostics in healthcare.

Learning outcomes

Having attended this webinar, you will be able to:

• Recognise the benefits and challenges of using digital diagnostics in healthcare
• Outline the digital diagnostics already in use and potential future developments
• Identify ways pharmacists can integrate digital diagnostics into their practice
• Provide guidance and support to patients using digital diagnostics, ensuring they understand how to effectively use them and integrate it into their overall treatment plan.

Tutors

• Mr Scott Gill
  Lead Pharmacist, Ards Federation
• Ms Michelle McGeown
  Physiotherapy Clinical Lead in Pain Management
• Ms Natasha Moore
  Better Days Pain Support Programme Co-ordinator

Aim

To provide an overview of self-management strategies for people living with chronic pain.

Learning outcomes

Having attended this webinar, you will be able to:

• Understand the different pain classification systems and their significance
• Explain the ""Biopsychosocial model of pain"" and its importance in delivering patient-centred care
• Recommend effective self-management strategies to people living with chronic pain
• Encourage patients to participate in structured self-management programmes and signpost to self-help resources
• Acknowledge the impact of pain from a patient's perspective and how it affects their quality of life.

Tutors

• Ms Danielle McGranaghan
  Advanced Nurse Practitoner

Aim

To provide an overview of the management of stroke and transient ischaemic attack (TIA)

Learning outcomes

Having attended this webinar, you will be able to:

• Promptly recognise the key signs and symptoms of stroke and TIA
• Identify the modifiable and non-modifiable risk factors associated with stoke and TIA
• Describe the steps in the initial management of stroke and TIA
• Conduct follow-up care for individuals with stroke or TIA, ensuring initiation, continuation and regular review of secondary prevention strategies
• Recognise and manage the consequences and complications of stroke effectively.

Tutors

• Dr Heather Bell
  Associate Postgraduate Pharmacy Dean
• Mrs Wendy Evans
  FTY Lead, NICPLD

Aim

To provide an overview of the 2025/26 Foundation Training Year (FTY).

Learning outcomes

Having attended this webinar, you will be able to:

• Describe the key changes to the FTY 2025/26 programme and the three training pathways available for trainee pharmacists
• Explain the requirements of the FTY framework, including the prescribing practice period (PPP) requirements
• Outline the curriculum and assessment strategy for the FTY 2025/26
• Discuss the role and responsibilities of educational supervisors (ES), designated prescribing
practitioners (DPP), and other practice supervisors in supporting trainee pharmacists
• Participate in an Q&A session to discuss any queries about the 2025/26 FTY.

Tutors

• Mr Timothy McClure
  Senior Clinical Practice Pharmacist

Aim

To equip participants with the knowledge and skills required to identify and manage patients at risk of developing Type 2 Diabetes.

Learning outcomes

Having attended this webinar, you will be able to:

• Recognise the main modifiable and non-modifiable risk factors for developing type 2 diabetes
• Identify those patients at risk of developing type 2 diabetes
• Provide patient education and lifestyle advice to patients at risk of developing type 2 diabetes
• Appreciate the importance of managing lipids and blood pressure to minimise cardiovascular risk

Tutors

• Dr Catherine Shaw
  FTY Lead, NICPLD
• Mrs Mairead Conlon
  FTY Lead, NICPLD

Aim

To provide an overview of the 2025/26 Foundation Training Year (FTY).

Learning outcomes

Having attended this webinar, you will be able to:

• Describe the key changes to the FTY 2025/26 programme and the three training pathways available for trainee pharmacists
• Explain the requirements of the FTY framework, including the prescribing practice period (PPP) requirements
• Outline the curriculum and assessment strategy for the FTY 2025/26
• Discuss the role and responsibilities of educational supervisors (ES), designated prescribing
practitioners (DPP), and other practice supervisors in supporting trainee pharmacists
• Participate in an Q&A session to discuss any queries about the 2025/26 FTY.

Tutors

• Ms Nadia Malik
  Pracatice Pharmacist

Aim

To equip pharmacists with the knowledge and confidence to safely prescribe and advise patients on the use of glucagon-like peptide-1 (GLP-1) and dual GLP-1/ glucose-dependent insulinotropic polypeptide (GIP) receptor agonists in adults with type 2 diabetes.

Learning outcomes

Having attended this webinar, you will be able to:

• Explain the mechanism of action of GLP-1 and dual GLP-1/GIP receptor agonists and describe the clinical benefits of therapies
• Compare the different GLP-1 and GLP-1/GIP receptor agonists available and outline when they can be prescribed
• Identify key safety considerations, including common side effects, contraindications, drug interactions and monitoring requirements
• Provide comprehensive advice and support to patients on the use of GLP-1 and GLP-1/GIP analogues

Tutors

• Mr Michael McCabe
  Pharmacy Advisor, SPPG
• Dr Helen Toal
  Consultant Psychiatrist, BHSCT
• Mr Clifford McElhinney
  Community Pharmacist

Aim

To enable pharmacists to effectively contribute to the shared care team delivering substitution therapy services in Northern Ireland.

Learning outcomes

Having completed this workshop you will be able to:

• discuss the Northern Ireland Guidelines on substitution treatments for opioid dependence
• describe the pharmacological properties of methadone and buprenorphine
• understand the rationale for initiating treatment and thereafter the stabilisation of treatment
• supervise consumption in individuals appropriately
• understand other harm reduction services available from community pharmacy
• appreciate the role of all professionals involved in the shared care of service users.

Tutors

• Mr Scott Gill
  Lead Pharmacist, Ards Federation
• Ms Davina Carr
  Clinical Teaching Fellow and GP

Aim

To provide an overview of the pharmacological management of chronic pain.

Learning outcomes

Having attended this webinar, you will be able to:

• Understand the latest NICE guidance for treating chronic pain, encompassing primary and secondary chronic pain
• Outline the pharmacological management of chronic pain, including nociceptive, neuropathic, and nociplastic pain
• Communicate the risks associated with dependence-forming medicines with patients
• Undertake a medication review in consultation with the patient and deprescribe or reduce inappropriate medicines through a shared decision-making process.

Tutors

• Ms Tiffany Ki
  OPAT / Microbiology Pharmacist

Aim

To provide an overview of a range of common antimicrobial infections and how these can be effectively managed in practice.

Learning outcomes

Having attended this webinar, you will be able to:

• Recognise the clinical features of a range of common antimicrobial infections
• Describe the management strategies for a range of common antimicrobial infections
• Provide comprehensive advice and support to patients regarding the management of common antimicrobial infections
• Identify red flag symptoms and refer appropriately